Results of General Meeting

Pharma C Investments PLC
11 December 2023
 

11 December 2023

 

 

Pharma C Investments PLC

 

("Pharma C" or the "Company")

 

Results of General Meeting

 

Pharma C (AQSE: PCIL) held its general meeting ("GM") today at 11:00am.  All resolutions set out in the Company's Notice of General Meeting dated 24 November 2023 were proposed and approved.

 

The Directors of Pharma C take responsibility for this announcement. 

 

For further information please visit www.pharmacinvestments.com

 

Pharma C Investments


Gavin Sathianathan, Investment Strategy Director

gavin@pharmacinvestments.com

First Sentinel Corporate Finance

 

Brian Stockbridge, Corporate Adviser

 

 +44 20 3855 5551

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings